课题基金 / 基金详情

Identifying drug-resistant Candida species using SuperSelective primer PCR

Identifying drug-resistant Candida species using SuperSelective primer PCR
使用超选择性引物 PCR 鉴定耐药念珠菌种类
批准号:
10575446
负责人:
NEERAJ CHAUHAN
金额:
$26.99万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-11-25 至 2024-10-31

项目摘要

项目成果

NEERAJ CHAUHAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Candida auris is an emerging pan-multidrug-resistant fungal pathogen and presents a serious global health threat. Importantly, C. auris is the first fungal pathogen showing pronounced and sometimes untreatable clinical drug resistance to all known antifungal classes, including echinocandins azoles, and amphotericin B. However, the diagnostic tools for the early detection of drug resistance in C. auris infections are either inadequate or not sensitive enough for the identification of drug resistant clinical isolates. Thus, the combination of antifungal drug resistance, along with a lack of sensitive diagnostic assays impair efficient therapeutic strategies to overcome or prevent drug resistance in C. auris. Hence, the overall objective is to develop and validate SuperSelective PCR assays for the detection of mutations in genes encoding echinocandin or azole resistance, despite an abundant background of wild-type C. auris DNA. We hypothesize that SuperSelective PCR assays will detect mutant C. auris with a sensitivity exceeding 1:104 mutant:wild type for single nucleotide polymorphisms at genetic loci conferring echinocandin or azole resistance. The premise is based on our proof-of-concept work with an C. auris FKS1 mutation conferring high-level echinocandin resistance. We expect to test our hypothesis and to accomplish the objectives by pursuing two Specific Aims: 1) Develop and validate a novel SuperSelective PCR platform to detect mutations in C. auris genes conferring resistance to echinocandin and azole antifungal drugs. 2) Validate SuperSelective PCR assays to detect echinocandin and azole heteroresistance in the kidney homogenates of mice with active candidiasis. The payoffs of this proposal are expected to be significant, because the proposed study will develop a novel SuperSelective primer PCR platform to identify mutations, heteroresistant or tolerant clinical C. auris isolates. It will also provide a framework for mechanistic understanding of multidrug resistance in C. auris.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Candida albicans acetylome in fungal virulence
  • 批准号:
    9750616
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2016
  • 负责人:
    NEERAJ CHAUHAN
  • 依托单位:
The Candida albicans acetylome in fungal virulence
  • 批准号:
    9333188
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2016
  • 负责人:
    NEERAJ CHAUHAN
  • 依托单位:
Triazole hypersensitivity in Candida albicans
  • 批准号:
    7494745
  • 项目类别:
  • 资助金额:
    $6.83万
  • 财政年份:
    2008
  • 负责人:
    NEERAJ CHAUHAN
  • 依托单位:
Triazole hypersensitivity in Candida albicans
海外基金